Cancer firm expects NHS to fall short

A private company has invested around £30m in three new private cancer centres, underlining its belief that the NHS will fail to meet the rising demand for cancer treatments.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here